Biotec Pharmacon has today 06th January 2020 held an Extraordinary General
Meeting.
Please find enclosed the minutes from the extraordinary general meeting.
This information is subject of the disclosure requirements according to section
5-12 of the Norwegian Securities Trading Act.
For further information, please contact
Børge Sørvoll
CFO
borge.sorvoll@biotec.no